Cargando…

Exporting China’s Successes in Vaccine Preventable Hepatitis

Detalles Bibliográficos
Autor principal:	Rodewald, Lance E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422236/ https://www.ncbi.nlm.nih.gov/pubmed/34594711 http://dx.doi.org/10.46234/ccdcw2020.153

Ejemplares similares

Accelerating into Immunization Agenda 2030 with momentum from China’s successful COVID-19 vaccination campaign during dynamic COVID Zero
por: Rodewald, Lance E.
Publicado: (2023)

Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
por: Wang, Fuzhen, et al.
Publicado: (2021)

Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China
por: An, Zhijie, et al.
Publicado: (2021)

Animal Welfare Risks in Live Cattle Export from Australia to China by Sea
por: Hing, Stephanie, et al.
Publicado: (2021)

The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases
por: Wolf, Jayanthi, et al.
Publicado: (2020)

The export of hazardous industries in 2015
por: Castleman, Barry
Publicado: (2016)

Forty and Twenty Years Ago and Now — Virus Elimination Successes and New Challenges
por: Rodewald, Lance E.
Publicado: (2020)

Measles vaccination and prevention in big cities in China
por: Meina, Li, et al.
Publicado: (2015)

Hepatitis B vaccine adverse events in China: Risk control and regulation
por: Meina, Li, et al.
Publicado: (2014)

Jumping over the fence: RNA nuclear export revisited
por: Strambio-De-Castilla, Caterina
Publicado: (2013)

The landscape of vaccines in China: history, classification, supply, and price
por: Zheng, Yaming, et al.
Publicado: (2018)

Within you, without you: HIV-1 Rev and RNA export
por: Dayton, Andrew I
Publicado: (2004)

Invasive Bacterial Vaccine-Preventable Disease Surveillance: Successes and Lessons Learned in Bangladesh for a Sustainable Path Forward
por: Saha, Senjuti, et al.
Publicado: (2021)

How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19
por: Zou, Huachun, et al.
Publicado: (2020)

Proteomics identify nuclear export as a targetable pathway in neuroblastoma: Comment on “XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IκB”
por: Shah, Nilay
Publicado: (2021)

The driving force for mycolic acid export by mycobacterial MmpL3 is proton translocation
por: Parish, Tanya
Publicado: (2022)

Setting the Stage for the Next Great Vaccine Success Story
por: Freeman, Megan Culler
Publicado: (2022)

The value of research as a component of successful tobacco control in China
por: Koplan, Jeffrey P, et al.
Publicado: (2013)

Give me a SINE: how Selective Inhibitors of Nuclear Export modulate autophagy and aging
por: Kumar, A.V., et al.
Publicado: (2018)

Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning
por: Nayagam, Shevanthi, et al.
Publicado: (2020)

Vaccine pricing strategies in China
por: Zhang, Haonan, et al.
Publicado: (2023)

“If the world doesn’t share the vaccine, the virus will take on the world”
por: Yin, Zundong, et al.
Publicado: (2021)

Vaccinate with Confidence and Finish Strong
por: Rodewald, Lance, et al.
Publicado: (2022)

Compliance among infants exposed to hepatitis B virus in a post-vaccination serological testing program in four provinces in China
por: Zheng, Hui, et al.
Publicado: (2019)

Vaccination strategies for the prevention of meningococcal disease
por: Vuocolo, Scott, et al.
Publicado: (2018)

Is hepatitis B birth dose vaccine needed in Africa?
por: Tamandjou, Cynthia Raissa, et al.
Publicado: (2017)

Hepatitis B prevalence in pregnant women in China: Progress and realities
por: Dusheiko, Geoffrey
Publicado: (2021)

Progress in the Development of Animal Rabies Vaccines in China
por: Yin, Chunsheng
Publicado: (2021)

Comment on “Will HPV vaccination prevent cervical cancer”
por: Zhang, Shaokai, et al.
Publicado: (2020)

Prevention and Treatment of Pneumoconiosis in the Context of Healthy China 2030
por: Wang, Huanqiang, et al.
Publicado: (2023)

Infection prevention and control of the Ebola outbreak in Liberia, 2014–2015: key challenges and successes
por: Cooper, Catherine, et al.
Publicado: (2016)

Release the ballast: Glioblastoma rises above radiation therapy by exporting miR-603 in extracellular vesicles to become treatment-resistant
por: Bayik, Defne, et al.
Publicado: (2020)

Macao's COVID-19 responses: From virus elimination success to vaccination rollout challenges
por: McCartney, Glenn, et al.
Publicado: (2021)

Hepatitis B vaccine and NK cells: a new player in memory
por: Hofmann, Maike, et al.
Publicado: (2021)

Exporting Essentials : selling products and services to the world successfully
por: Delaney, Laurel J
Publicado: (2014)

The role of hazard vulnerability assessments in disaster preparedness and prevention in China
por: Du, Yan, et al.
Publicado: (2015)

Enhancing Injury Prevention and Control in China: Establishment of Evidence System
por: Duan, Leilei, et al.
Publicado: (2023)

A successful partnership model for COVID‐19 vaccination in Aboriginal communities in New South Wales
por: Riley, Tamara, et al.
Publicado: (2022)

Prioritization of Vaccines for Inclusion into China’s Expanded Program on Immunization: Evidence from Experts’ Knowledge and Opinions
por: Ma, Chao, et al.
Publicado: (2022)

Access to Vaccination Information and Confidence/Hesitancy towards Childhood Vaccination: A Cross-Sectional Survey in China
por: Du, Fanxing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q9fdrn47b6dt85nufghe1hc746